SciClone Pharmaceuticals, Inc. to Present at UBS Warburg Global Life Sciences Conference

SAN MATEO, CA--(MARKET WIRE)--Sep 13, 2007 -- SciClone Pharmaceuticals, Inc. (NasdaqGM:SCLN - News) today announced that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York. Friedhelm Blobel, Ph.D., SciClone’s President and Chief Executive Officer, will present a corporate overview and business update on Monday, September 24, 2007 at 1:00 pm ET.

MORE ON THIS TOPIC